Vertebral body insufficiency fractures: detection of vertebrae at risk on standard CT images using texture analysis and machine learning.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works by Vokinger, Kerstin N.
Results: 21
1
2
Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011–2022).
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 10, p. 1442, doi. 10.7326/ANNALS-24-00614
- By:
- Publication type:
- Article
3
Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 10, p. 1413, doi. 10.7326/M23-0623
- By:
- Publication type:
- Article
4
Comparison of Uptake and Prices of Biosimilars in the US, Germany, and Switzerland.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2244670, doi. 10.1001/jamanetworkopen.2022.44670
- By:
- Publication type:
- Article
5
Therapeutic Value Assessments of Novel Medicines in the US and Europe, 2018-2019.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e226479, doi. 10.1001/jamanetworkopen.2022.6479
- By:
- Publication type:
- Article
6
Comparative Analysis of Drug Shortages in the US and Germany (2016 – 2023).
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 2, p. 488, doi. 10.1017/jme.2024.105
- By:
- Publication type:
- Article
7
Lost in Anonymization — A Data Anonymization Reference Classification Merging Legal and Technical Considerations.
- Published in:
- Journal of Law, Medicine & Ethics, 2020, v. 48, n. 1, p. 228, doi. 10.1177/1073110520917025
- By:
- Publication type:
- Article
8
AI Devices in Neurology—Moving From Diagnosis to Prognosis.
- Published in:
- 2025
- By:
- Publication type:
- Opinion
9
Launch and Postlaunch Price Developments of New Drugs in the US, Germany, and Switzerland.
- Published in:
- JAMA Health Forum, 2024, v. 5, n. 11, p. e244461, doi. 10.1001/jamahealthforum.2024.4461
- By:
- Publication type:
- Article
10
Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses.
- Published in:
- JAMA Health Forum, 2024, v. 5, n. 8, p. e242530, doi. 10.1001/jamahealthforum.2024.2530
- By:
- Publication type:
- Article
11
Do Managed Entry Agreements Contribute to Lower Pharmaceutical Spending?
- Published in:
- 2023
- By:
- Publication type:
- Opinion
12
Investments in Research and Development for Supplemental Drug Indications—Implications for Drug Price Negotiations.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
13
Negotiating Drug Prices in the US—Lessons From Europe.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
14
Lifecycle Regulation of Artificial Intelligence- and Machine Learning-Based Software Devices in Medicine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
15
Correction to: impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous <sup>18</sup>F-choline PET/MRI for prostate cancer.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0413-5
- By:
- Publication type:
- Article
16
Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous <sup>18</sup>F-choline PET/MRI for prostate cancer.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0390-8
- By:
- Publication type:
- Article
17
Reforming the World Health Organization's Essential Medicines List: Essential but Unaffordable.
- Published in:
- 2022
- By:
- Publication type:
- journal article
18
Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
19
New Treatments for Migraine-Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe.
- Published in:
- 2022
- By:
- Publication type:
- journal article
20
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
21
Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 8, p. e222685, doi. 10.1001/jamahealthforum.2022.2685
- By:
- Publication type:
- Article